140 results
Page 3 of 7
8-K
EX-10.1
1pg6ul orxmr
13 Aug 21
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.1
eygcv
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
S-3ASR
kpz6nw 4iqr
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-1.2
bhe404j9x pdchgq1p
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-5.1
bawza1y7 4l
10 Aug 20
Automatic shelf registration
5:01pm
424B5
6oxgl r3ek3flges4vrp
2 Jun 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-5.1
mzbmbq8k uv2zh3
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
8-K
EX-1.1
pb38r8 fizru9l6c
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
424B5
scbx5yj0n3m
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-10.1
zzwwkds48477dukugrsn
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
8-K
9kd850xf1 nrj4g7u
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
424B5
x52lmjwa
22 Jan 20
Prospectus supplement for primary offering
5:31pm
8-K
EX-1.1
ylvodjvsqs8a4ecz9m
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm